USANA Health Sciences Inc (USNA)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 923,232 929,999 950,124 976,483 1,001,860 1,041,382 1,082,496 1,155,009 1,190,168 1,235,586 1,258,823 1,180,028 1,137,751 1,095,421 1,057,506 1,054,531 1,060,902 1,088,627 1,124,796 1,170,240
Receivables US$ in thousands 7,201 7,213 7,163 7,420 8,762
Receivables turnover 128.21 138.90 166.15 153.34 121.08

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $923,232K ÷ $7,201K
= 128.21

The receivables turnover for USANA Health Sciences Inc demonstrates a fluctuating trend over the past few quarters. The ratio, which measures how efficiently a company is collecting cash from its credit sales, has shown a high level of turnover in recent periods. In particular, the turnover ratios for December 31, 2023, and December 31, 2022, are notably high at 128.21 and 138.90, respectively.

A high receivables turnover indicates that the company is collecting its accounts receivables quickly, which is generally a positive sign of strong liquidity and effective credit management. However, the lack of data for some periods makes it challenging to assess the trend accurately.

It would be helpful to analyze the reasons behind the fluctuations in the receivables turnover ratio and assess whether they are driven by changes in sales practices, payment terms, customer creditworthiness, or other factors. By conducting a more in-depth analysis of the components influencing the receivables turnover, a clearer picture can be obtained to evaluate the company's overall financial health and efficiency in managing its accounts receivables.